Loading...
XNYS
USNA
Market cap554mUSD
Jun 12, Last price  
29.78USD
1D
-0.23%
1Q
2.20%
Jan 2017
-51.34%
Name

USANA Health Sciences Inc

Chart & Performance

D1W1MN
P/E
13.20
P/S
0.65
EPS
2.26
Div Yield, %
—
Shrs. gr., 5y
-3.43%
Rev. gr., 5y
-4.23%
Revenues
855m
-7.22%
327,742,000374,190,000423,149,000429,012,000436,940,000517,644,000581,939,000648,726,000718,175,000790,471,000918,499,0001,006,083,0001,047,265,0001,189,248,0001,060,902,0001,134,644,0001,186,464,000998,601,000921,010,000854,503,000
Net income
42m
-34.11%
38,994,00041,266,00045,317,00029,945,00033,556,00045,651,00050,752,00066,433,00079,024,00076,636,00094,672,000100,041,00062,535,000126,224,000100,526,000124,664,000116,505,00069,350,00063,788,00042,030,000
CFO
61m
-13.66%
48,018,00060,520,00057,219,00045,956,00032,469,00066,108,00070,108,00092,805,00098,893,000105,185,000111,466,000137,030,000123,783,000152,119,000126,733,000160,401,000121,227,000103,902,00070,641,00060,992,000
Earnings
Jul 21, 2025

Profile

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
URL
https://www.usana.com/
IPO date
Oct 28, 1993
Employees
1,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122022‑002021‑002019‑122018‑122017‑122016‑122016‑00
Income
Revenues
854,503
-7.22%
921,010
-22.37%
998,601
-11.99%
Cost of revenue
424,480
445,128
902,550
Unusual Expense (Income)
NOPBT
430,023
475,882
96,051
NOPBT Margin
50.32%
51.67%
9.62%
Operating Taxes
34,321
38,665
39,271
Tax Rate
7.98%
8.12%
40.89%
NOPAT
395,702
437,217
56,780
Net income
42,030
-34.11%
63,788
-45.25%
69,350
-44.37%
Dividends
Dividend yield
Proceeds from repurchase of equity
(9,444)
(11,599)
(25,382)
BB yield
1.38%
1.12%
2.47%
Debt
Debt current
23,000
8,064
6,892
Long-term debt
6,013
7,278
14,572
Deferred revenue
(7,680)
Other long-term liabilities
18,163
12,158
14,173
Net debt
(152,755)
(315,078)
(269,856)
Cash flow
Cash from operating activities
60,992
70,641
103,902
CAPEX
(10,073)
(14,494)
(10,400)
Cash from investing activities
(213,090)
(11,975)
(12,370)
Cash from financing activities
9,553
(14,237)
(30,088)
FCF
400,951
439,183
59,452
Balance
Cash
181,768
330,420
288,420
Long term investments
2,900
Excess cash
139,043
284,370
241,390
Stockholders' equity
510,516
431,541
378,868
Invested Capital
488,452
233,054
197,940
ROIC
109.69%
203.96%
29.20%
ROCE
68.09%
91.17%
21.66%
EV
Common stock shares outstanding
19,162
19,345
19,310
Price
35.69
-33.41%
53.60
-47.04%
53.20
-31.00%
Market cap
683,892
-34.04%
1,036,892
-49.63%
1,027,292
-37.32%
EV
585,360
721,814
757,436
EBITDA
444,562
496,277
117,461
EV/EBITDA
1.32
1.45
6.45
Interest
281
262
192
Interest/NOPBT
0.07%
0.06%
0.20%